Interpharm Holdings, Inc. Stock

Stocks

IPAH

US4605881063

Pharmaceuticals

OTC Markets Traded
Market Closed - 15:26:41 2023-06-14 EDT 5-day change 1st Jan Change
0.001000 USD +900.00% Intraday chart for Interpharm Holdings, Inc. +99,900.00% +99,900.00%
1 week+99,900.00%
Current month+99,900.00%

Valuation: Interpharm Holdings, Inc.

Market Cap 1.07M 958K 883K 801K 1.52M 100M 1.56M 10.57M 4.21M 53.64M 4.01M 3.92M 170M P/E 2006
-9.26x
P/E 2007 -4.96x
Enterprise Value 27.54M 24.7M 22.76M 20.67M 39.12M 2.58B 40.22M 273M 109M 1.38B 103M 101M 4.37B EV / Sales 2006
1.63x
EV / Sales 2007 1.47x
Free-Float
100%
Yield 2006 *
-
Yield 2007 -
1 day+900.00%
1 week+99,900.00%
Current month+99,900.00%
1 month+99,900.00%
3 months+99,900.00%
6 months+99,900.00%
Current year+99,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.01
10 years 0
Extreme 1.0E-6
0.02
Change 5-day change 1-year change 3-year change Capi.($)
+900.00%+99,900.00%+99,900.00%+99,900.00% 66
+1.44%+1.63%+48.17%+139.63% 1,276B
-0.47%+5.49%+49.03%+90.68% 676B
+0.20%+2.76%+34.37%+112.06% 519B
-0.83%+0.58%+37.93%+66.79% 388B
-0.48%+2.34%+70.66%+46.02% 365B
-0.91%-0.80%+27.96%+57.39% 307B
-0.13%-1.06%+3.04%+35.40% 287B
0.00%+0.86%+43.74%+74.04% 252B
+0.92%+2.03%+44.62%+125.07% 212B
Average +89.79%+2.10%+10,025.95%+10,064.71% 428B
Weighted average by Cap. -0.33%+2.51%+42.71%+96.51%

Financials

2006 2007
Net sales 63.36M 56.82M 52.36M 47.55M 90M 5.94B 92.51M 627M 250M 3.18B 238M 233M 10.06B 75.59M 67.79M 62.47M 56.73M 107M 7.09B 110M 748M 298M 3.8B 284M 278M 12B
Net income -3.79M -3.4M -3.13M -2.84M -5.38M -355M -5.53M -37.51M -14.94M -190M -14.22M -13.92M -602M -14.06M -12.61M -11.62M -10.55M -19.97M -1.32B -20.53M -139M -55.43M -706M -52.76M -51.64M -2.23B
Net Debt 14.2M 12.73M 11.74M 10.66M 20.17M 1.33B 20.73M 141M 55.99M 713M 53.29M 52.16M 2.25B 26.47M 23.74M 21.88M 19.87M 37.61M 2.48B 38.66M 262M 104M 1.33B 99.35M 97.24M 4.2B
Logo Interpharm Holdings, Inc.
Interpharm Holdings, Inc., through its wholly owned subsidiary, Interpharm, Inc., is engaged in the business of developing, manufacturing and marketing generic prescription strength and over-the-counter pharmaceuticals. The Company sells its products under its own label to the major retailers, wholesalers, managed care organizations and national distributors, and under private label to wholesalers, distributors, repackagers and other manufacturers. During the fiscal year ended June 30, 2007 (fiscal 2007), the Company manufactured and marketed 36 generic pharmaceutical products, which represent various oral dosage strengths for 11 products and different dosage strengths for 25 of these products.
Employees
670
  1. Stock Market
  2. Stocks
  3. IPAH Stock